Transcription profiling of cetuximab-resistant human colorectal cancer cell lines revealed that the expression of the MMR pathway-related genes, MLH1 and MSH2, as well as the HR pathway-related genes, BRCA2 and RAD51, was decreased. The gene discussed is MSH2; the disease is colorectal cancer.